Literature DB >> 10529385

Cloning and characterization of a novel p21(Cip1/Waf1)-interacting zinc finger protein, ciz1.

K Mitsui1, A Matsumoto, S Ohtsuka, M Ohtsubo, A Yoshimura.   

Abstract

p21(Cip1/Waf1) inhibits cell-cycle progression by binding to G1 cyclin/CDK complexes and proliferating cell nuclear antigen (PCNA) through its N- and C-terminal domains, respectively. Here, we report a novel p21(Cip1/Waf1)-interacting protein, Ciz1 (for Cip1 interacting zinc finger protein), which contains polyglutamine repeats and glutamine-rich region in the N-terminus as well as three zinc-finger motifs and one MH3 (matrin 3-homologous domain 3) in the C-terminal region. Ciz1 bound to the N-terminal, the CDK2-interacting part of p21(Cip1/Waf1), and the interaction was disrupted by the overexpression of CDK2. A region of about 150 amino acids containing the first zinc-finger motif in Ciz1 was the binding site for p21(Cip1/Waf1). When Ciz1 and p21(Cip1/Waf1) were individually overexpressed in U2-OS cells, they mostly localized in the nucleus. However, coexpression of Ciz1 induced cytoplasmic distribution of p21(Cip1/Waf1). These data indicate that Ciz1 is a unique nuclear protein that regulates the cellular localization of p21(Cip1/Waf1). Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10529385     DOI: 10.1006/bbrc.1999.1516

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  26 in total

1.  Mutations in CIZ1 cause adult onset primary cervical dystonia.

Authors:  Jianfeng Xiao; Ryan J Uitti; Yu Zhao; Satya R Vemula; Joel S Perlmutter; Zbigniew K Wszolek; Demetrius M Maraganore; Georg Auburger; Barbara Leube; Katja Lehnhoff; Mark S LeDoux
Journal:  Ann Neurol       Date:  2012-03-23       Impact factor: 10.422

2.  Consequences of Cre-mediated deletion of Ciz1 exon 5 in mice.

Authors:  Jianfeng Xiao; Mohammad Moshahid Khan; Satya Vemula; Jun Tian; Mark S LeDoux
Journal:  FEBS Lett       Date:  2018-08-29       Impact factor: 4.124

3.  Motor phenotypes and molecular networks associated with germline deficiency of Ciz1.

Authors:  Jianfeng Xiao; Satya R Vemula; Yi Xue; Mohammad M Khan; Korah P Kuruvilla; Esther M Marquez-Lona; Madison R Cobb; Mark S LeDoux
Journal:  Exp Neurol       Date:  2016-05-07       Impact factor: 5.330

4.  Ciz1 cooperates with cyclin-A-CDK2 to activate mammalian DNA replication in vitro.

Authors:  Nikki A Copeland; Heather E Sercombe; Justin F X Ainscough; Dawn Coverley
Journal:  J Cell Sci       Date:  2010-03-09       Impact factor: 5.285

5.  Repeat E anchors Xist RNA to the inactive X chromosomal compartment through CDKN1A-interacting protein (CIZ1).

Authors:  Hongjae Sunwoo; David Colognori; John E Froberg; Yesu Jeon; Jeannie T Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-18       Impact factor: 11.205

6.  Myopodin, a synaptopodin homologue, is frequently deleted in invasive prostate cancers.

Authors:  F Lin; Y P Yu; J Woods; K Cieply; B Gooding; P Finkelstein; R Dhir; D Krill; M J Becich; G Michalopoulos; S Finkelstein; J H Luo
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

7.  PDRG1, a novel tumor marker for multiple malignancies that is selectively regulated by genotoxic stress.

Authors:  Lingyan Jiang; Xiuquan Luo; Jingxue Shi; Hong Sun; Qing Sun; M Saeed Sheikh; Ying Huang
Journal:  Cancer Biol Ther       Date:  2011-03-15       Impact factor: 4.742

Review 8.  The enigmatic ERH protein: its role in cell cycle, RNA splicing and cancer.

Authors:  Meng-Tzu Weng; Ji Luo
Journal:  Protein Cell       Date:  2013-11       Impact factor: 14.870

9.  Differential detection of alternatively spliced variants of Ciz1 in normal and cancer cells using a custom exon-junction microarray.

Authors:  Faisal A Rahman; Naveed Aziz; Dawn Coverley
Journal:  BMC Cancer       Date:  2010-09-10       Impact factor: 4.430

10.  Variant Ciz1 is a circulating biomarker for early-stage lung cancer.

Authors:  Gillian Higgins; Katherine M Roper; Irene J Watson; Fiona H Blackhall; William N Rom; Harvey I Pass; Justin F X Ainscough; Dawn Coverley
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.